Migraine, quality of life, and depression
A population-based case–control study
Abstract
Objective: This study reports on the influence of migraine and comorbid depression on health-related quality of life (HRQoL) in a population-based sample of subjects with migraine and nonmigraine controls.
Methods: Two population-based studies of similar design were conducted in the United States and United Kingdom. A clinically validated, computer-assisted telephone interview was used to identify individuals with migraine, as defined by the International Headache Society, and a nonmigraine control group. During follow-up interviews, 389 migraine cases (246 US, 143 UK) and 379 nonmigraine controls (242 US, 137 UK) completed the Short Form (SF)–12, a generic HRQoL measure, and the Primary Care Evaluation of Mental Disorders, a mental health screening tool. The SF-12 measures HRQoL in two domains: a mental health component score (MCS-12) and a physical health component score (PCS-12).
Results: In the United States and United Kingdom, subjects with migraine had lower scores (p < 0.001) on both the MCS-12 and PCS-12 than their nonmigraine counterparts. Significant differences were maintained after controlling for gender, age, and education. Migraine and depression were highly comorbid (adjusted prevalence ratio 2.7, 95% CI 2.1 to 3.5). After adjusting for gender, age, and education, both depression and migraine remained significantly and independently associated with decreased MCS-12 and PCS-12 scores. HRQoL was significantly associated with attack frequency (for MCS-12 and PCS-12) and disability (MCS-12).
Conclusions: Subjects with migraine selected from the general population have lower HRQoL as measured by the SF-12 compared with nonmigraine controls. Further, migraine and depression are highly comorbid and each exerts a significant and independent influence on HRQoL.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
McHorney C, Ware J, Raczek A. The MOS 36-item short from health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental constructs. Med Care . 1993; 31: 247–263.
2.
Stewart A, Hays R, Ware J. The MOS short form general health survey: reliability and validity in a patient population. Med Care . 1988; 26: 724–735.
3.
Osterhaus J, Townsend R, Gandek B, et al. Measuring functional status and well-being of patients with migraine headache. Headache . 1994; 34: 337–343.
4.
Solomon G, Skobieranda F, Gragg L. Quality of life and well-being of headache patients: measurement by the medical outcomes study instrument. Headache . 1993; 33: 351–358.
5.
Dahlof C, Dimenas E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia . 1995; 15: 31–36.
6.
Lipton R, Stewart W. Population-based clinical trials in headache. In: Olesen J, Tfelt-Hansen P, eds. Headache treatment. Trial methodology and new drugs. Philadelphia: Lippincott-Raven, 1997: 65–70.
7.
Lipton R, Stewart W, Von Korff M. Burden of migraine: societal costs and therapeutic opportunities. Neurology . 1997; 48 (suppl 3): S4–S9.
8.
Lipton R, Stewart W, Simon D. Medical consultation for migraine: results of the American Migraine Study. Headache . 1998; 38: 87–90.
9.
Linet M, Celentano D, Stewart W. Headache characteristics associated with physician consultation: a population-based survey. Am J Prev Med . 1991; 7: 40–46.
10.
Terwindt GM, Ferrari MD, Tijhuis M, et al. The impact of migraine on quality of life in the general population: The GEM study. Neurology . 2000; 55: 624–629.
11.
Lipton R, Liberman J, Kolodner K, et al. Migraine headache disability and quality-of-life: a population-based case-control study. Headache . 1999; 39: 365.Abstract.
12.
Silberstein S, Lipton R, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia . 1995; 15: 358–369.
13.
Merikangas K, Angst J, Isler H. Migraine and psychopathology: results of the Zurich cohort study of young adults. Arch Gen Psychiatry . 1990; 47: 849–853.
14.
Breslau N, Davis G. Migraine, major depression and panic disorder: a prospective epidemiologic study of young adults. Cephalalgia . 1992; 12: 85–90.
15.
Breslau N, Davis G. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res . 1993; 27: 211–221.
16.
Breslau N, Davis G, Schultz L, et al. Joint 1994 Wolff Award Presentation. Migraine and major depression: A longitudinal study. Headache . 1994; 34: 387–393.
17.
Breslau N, Schultz L, Stewart W, et al. Headache and major depression: is the association specific to migraine? Neurology . 2000; 54: 308–313.
18.
Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology . 1996; 16: 231–238.
19.
Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia . 1988; 8 (suppl 7): 1–96.
20.
Stewart W, Lipton R, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology . 1999; 53: 988–994.
21.
Ware J, Kosinski M, Keller S. A 12-item short form health survey: construction of scales and preliminary tests of reliability and validity. Med Care . 1996; 34: 220–233.
22.
Hahn S, Kroenke K, Williams J, et al. Primary care evaluation of mental disorders: PRIME-MD. In: Maruish M, ed. The use of psychological testing for treatment planning and outcome assessment, 2nd ed. Mahwah, NJ: Lawrence Earlbaum Associates, 1999.
23.
Spitzer R, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study. JAMA . 1995; 274: 1511–1517.
24.
Kobak K, Taylor L, Dottl S, et al. A computer-administered telephone interview to identify mental disorders. JAMA . 1997; 278: 905–910.
25.
Wells K, Stewart A, Hays R, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA . 1989; 262: 914–919.
26.
Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States: relation to age, income, race and other sociodemographic factors. JAMA . 1992; 267: 64–69.
Information & Authors
Information
Published In
Copyright
© 2000.
Publication History
Received: February 11, 2000
Accepted: July 11, 2000
Published online: September 12, 2000
Published in print: September 12, 2000
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Funções executivas e atencionais no paciente com enxaqueca, Headache Medicine, 15, 1, (18-24), (2024).https://doi.org/10.48208/HeadacheMed.2024.5
- Impact of Migraine on Family Members – A Cross-sectional Study in Southern Part of India, Annals of African Medicine, 23, 3, (295-298), (2024).https://doi.org/10.4103/aam.aam_144_23
- Characteristics and quality of life of people living with comorbid disorders in substance use recovery residences, Frontiers in Public Health, 12, (2024).https://doi.org/10.3389/fpubh.2024.1412934
- Analysis of Factors Affecting the Quality of Life of Migraine Patients, Advances in Clinical Medicine, 14, 05, (1563-1568), (2024).https://doi.org/10.12677/acm.2024.1451588
- Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life, Neurology, 102, 3, (2024)./doi/10.1212/WNL.0000000000208074
- Clinic-Based Characterization of Adolescents and Young Adults With Migraine, Neurology Clinical Practice, 14, 3, (2024)./doi/10.1212/CPJ.0000000000200294
- Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study, Cephalalgia, 44, 8, (2024).https://doi.org/10.1177/03331024241274343
- Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies, Cephalalgia, 44, 2, (2024).https://doi.org/10.1177/03331024231222923
- Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial , Headache: The Journal of Head and Face Pain, 64, 6, (632-642), (2024).https://doi.org/10.1111/head.14732
- Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME ( US ) study , Headache: The Journal of Head and Face Pain, 64, 8, (1027-1039), (2024).https://doi.org/10.1111/head.14729
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.